Birinapant increased the sub-G1 population in HNSCC HPV(−) cells in monotherapy, while the addition of the WEE1 inhibitor did not significantly affect cell cycle distribution. This evidence concerns the gene WEE1 and head and neck squamous cell carcinoma.